References
- Hara Y., Sato E., Miyagishi A., Aisaka A., Hibino T. Synthesis and badrenergic blocking action of a new thiazolyl-thiopropanolamine derivative. J Pharm Sci. 1978; 67: 1334–1335
- Hara Y., Sato E., Miyagishi A., Aono S., Nakatani H. Pharmacological properties of dl-2-(3′-t-butylamino-2′-hydroxy-propylthio)-4-(5′-carbamoyl-2′-thienyl) thiazole hydrochloride (S-596), a new b-adrenergic blocking agent. Folia Pharmacol Japon 1979; 75: 707–720
- Miyagishi A., Nakahara H., Hara Y., Nakatani H. Effects of the new b-adrenoceptor blocking agent, S-596 on the peripheral auto-nomic nervous system and smooth muscles. Arch Int Pharmacodyn Ther. 1983; 261: 222–237
- Hara Y., Nakahara H., Miyagishi A., Nakatani H. Anti-hypertensive effects of arotinolol (S-596), a new adrenergic b-blocking agent, in experimental hypertensive rats. Folia Pharmacol Japon 1983; 82: 103–116
- Miyagishi A., Nakahara H., Hara Y. Adrenergic blocking effects of arotinolol, a new combined a- and b-adrenoceptor blocking agent. Arch Int Pharmacodyn Ther. 1984; 271: 249–262
- Okamoto K., Yamori Y., Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974; 34(suppl I)I-143–I-53
- Yamori Y., Horie R., Handa H., Sato M., Fukase M. Pathogeneticsimilarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976; 7: 46–53
- Kazda S., Garthoff B., Luckhaus G. Mode of antihypertensive action of nitrendipine. J Cardiovasc Pharmacol. 1984; 6: S956–S962
- Nagaoka A. Pharmacological prevention of cerebral stroke in stroke-prone spontaneously hypertensive rats. J Hypertens 1986; 4(suppl 3)S523–S525
- Watanabe T. X., Kawashima K., Sokabe H. Chronic effects of enala-pril on blood pressure, stroke, plasma renin, urinary electrolytes and PGE2 excretion in stroke-prone spontaneously hypertensive rats. Japan J Pharmacol. 1985; 38: 419–427
- Nagaoka A., Suno M., Shibota M., Kakihana M. Effects of idebe-none (CV-2619) on neurological deficits, local cerebral blood flow, and energy metabolism in rats with experimental cerebral ischemia. Folia Pharmacol Japon 1984; 84: 303–309
- Weeks J. R., Jones J. A. Routine direct measurement of arterial pressure in unanesthetized rats. Proc Soc Exp Biol Med. 1960; 104: 646–648
- Yamori Y., Igawa T., Tagami M., Kanbe T., Nara Y., Kihara M., Horie R. Humoral trophic influence on cardiovascular structural changes in hypertension. Hypertension 1984; 6(suppl III)III27–III32
- Yamori Y. The stroke-prone spontaneously hypertensive rat: contribution to risk factor analysis and prevention of hypertensive diseases. Handbook of Hypertension, vol 4, Experimental and Genetic Models of Hypertension, W. de Jong. Elsevier, Amsterdam 1984; 240–255
- Yamori Y., Horie R., Akiguchi I., Nara Y., Ohtaka M., Fukase M. Pathogenetic mechanisms in the prevention of stroke in stroke-prone SHR. Progress in Brain Research: Hypertension and Brain Mechanism, W de Jong, A P Provoost, A P Shapiro. Elsevier, Amsterdam 1977; 219–234
- Blaes N., Boissel J-P. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol. 1983; 116: 167–172
- Noguchi T., Miyagishi A., Hara Y. Inhibitory effect of arotinolol on cultured vascular smooth muscle cell proliferation stimulated by norepinephrine. Japan J Pharmacol. 1989; 49(Suppl I)80P
- Miyagishi A., Maniwa T., Noguchi T., Miyano T., Hara Y. Prevention of cerebral stroke, cardiac and vascular hypertrophy in stroke-prone spontaneously hypertensive rats by arotinolol (Report II). Japan J Pharmacol. 1988; 46(Suppl I)264P